These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6389807)

  • 1. Aluminum toxicity in children with chronic renal failure.
    Polinsky MS; Gruskin AB
    J Pediatr; 1984 Nov; 105(5):758-61. PubMed ID: 6389807
    [No Abstract]   [Full Text] [Related]  

  • 2. [The role of aluminum in the human body].
    Strzałkowska D
    Postepy Hig Med Dosw; 1991; 45(3-4):257-79. PubMed ID: 1946095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical images: Aluminum-modified renal osteopathy.
    Buttgereit F; Loreck D; Burmester GR; Abendroth K
    Arthritis Rheum; 1997 Sep; 40(9):1724. PubMed ID: 9324031
    [No Abstract]   [Full Text] [Related]  

  • 4. Aluminum toxicity in relation to kidney disorders.
    King SW; Savory J; Wills MR
    Ann Clin Lab Sci; 1981; 11(4):337-42. PubMed ID: 7023347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aluminium poisoning: dialysis encephalopathy, osteomalacia, and anaemia.
    Wills MR; Savory J
    Lancet; 1983 Jul; 2(8340):29-34. PubMed ID: 6134894
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of aluminum-induced osteopathy with desferrioxamine in dialysis-dependent renal failure].
    Lechleitner P; Gmeiner R; Beck G; König P
    Wien Med Wochenschr; 1987 Aug; 137(14-15):355-60. PubMed ID: 3673100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aluminum in chronic hemodialysis. Possible influence on osteomalacic bone disease.
    Quarello F; Giachino G; Bossi P; Gilli G; Corrao G; Scursatone E; Jeantet A; Bossi R; Coppo R; Piccoli G; Vercellone A
    Minerva Nefrol; 1980; 27(4):635-44. PubMed ID: 7254691
    [No Abstract]   [Full Text] [Related]  

  • 8. Fracturing dialysis osteodystrophy and dialysis encephalopathy. An epidemiological survey.
    Parkinson IS; Ward MK; Feest TG; Fawcett RW; Kerr DN
    Lancet; 1979 Feb; 1(8113):406-9. PubMed ID: 84261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aluminum toxicity in patients with chronic renal failure].
    Wanic-Kossowska M; Grzegorzewska A; Płotast H
    Przegl Lek; 1995; 52(12):603-5. PubMed ID: 8834660
    [No Abstract]   [Full Text] [Related]  

  • 10. Aluminium in renal disease: current knowledge and future developments.
    Starkey BJ
    Ann Clin Biochem; 1987 Jul; 24 ( Pt 4)():337-44. PubMed ID: 3310831
    [No Abstract]   [Full Text] [Related]  

  • 11. Dialysis osteomalacia and aluminum toxicity: a form of renal osteodystrophy.
    Felsenfeld AJ
    ANNA J; 1985 Jun; 12(3):189-91. PubMed ID: 3848318
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of desferrioxamine in the treatment of dialysis encephalopathy.
    Ackrill P; Ralston AJ; Day JP
    Kidney Int Suppl; 1986 Feb; 18():S104-7. PubMed ID: 3457985
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening plasma aluminum levels in relation to aluminum bone disease among asymptomatic dialysis patients.
    Kausz AT; Antonsen JE; Hercz G; Pei Y; Weiss NS; Emerson S; Sherrard DJ
    Am J Kidney Dis; 1999 Oct; 34(4):688-93. PubMed ID: 10516350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy of aluminum overload (I).
    Pierides AM; Myli MP
    Contrib Nephrol; 1984; 38():65-77. PubMed ID: 6425013
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute aluminemic encephalopathy in chronic renal failure: the citrate factor.
    Bakir AA
    Int J Artif Organs; 1989 Dec; 12(12):741-3. PubMed ID: 2613353
    [No Abstract]   [Full Text] [Related]  

  • 16. Deferoxamine for the diagnosis and treatment of aluminum-associated osteodystrophy.
    Charhon S; el Yafi S; Gaillard M; Beruard M; Janin G; Accominotti M; Traeger J; Meunier PJ
    Contrib Nephrol; 1988; 64():160-9. PubMed ID: 3180823
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapy of aluminium overload (II).
    Ackrill P; Day JP
    Contrib Nephrol; 1984; 38():78-80. PubMed ID: 6713902
    [No Abstract]   [Full Text] [Related]  

  • 18. Cerebrospinal fluid aluminum levels following deferoxamine.
    Ellenberg R; King AL; Sica DA; Posner M; Savory J
    Am J Kidney Dis; 1990 Aug; 16(2):157-9. PubMed ID: 2382654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of fracturing renal osteodystrophy by desferrioxamine.
    Ackrill P; Day JP; Garstang FM; Hodge KC; Metcalfe PJ; Benzo Z; Hill K; Ralston AJ; Ball J; Denton J
    Proc Eur Dial Transplant Assoc; 1983; 19():203-7. PubMed ID: 6878234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exacerbation of aluminium encephalopathy after treatment with desferrioxamine.
    Lillevang ST; Pedersen FB
    Nephrol Dial Transplant; 1989; 4(7):676. PubMed ID: 2510071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.